British pharmaceutical company GlaxoSmithKline (GSK) has provided, through this year’s budget, investments worth RON 21 M (EUR 5M) for its factory located in Brasov, also for a laboratory that will be completed in 2012, reads the Ziarul Financiar newspaper. The company exports the medicines produced in Brasov to more than 50 countries from all over the world. “At the end of last year, exports exceeded 43 pc of the total output, in volume. We plan to raise exports to more than half the output volume, by increasing the number of destination countries and also by upping the number of medicines we produce,” said Pascal Prigent, CEO of GSK Romania. The projects developed by GSK in Brasov are also important because the Europharm factory ranges among the largest pharmaceutical producers in the country, with a turnover of RON 405.9 M (about EUR 96 M) in 2009.